Edwards Lifesciences Corporation

NYSE:EW

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

🔬 Clinical Trials

💻 Telehealth

Location

United States

Market Cap

USD 43.31 B

Share Price

USD 73.83

Avg Daily Volume

4,793,798

Change (1 day)

-0.20%

Change (1 year)

-16.90%

Change (YTD)

-0.27%

Edwards Lifesciences Corporation Share Price Year-To-Date (YTD) return on June 20, 2025: -0.27%

Edwards Lifesciences Corporation Share Price Year-To-Date (YTD) return is -0.27% on June 20, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

Edwards Lifesciences Corporation 52-week low Share Price is USD 93.78 on June 20, 2025, which is 27.02% above the current Share Price.
Edwards Lifesciences Corporation 52-week low Share Price is USD 59.70 on June 20, 2025, which is -19.14% below the current Share Price.
Edwards Lifesciences Corporation average Share Price for the last 52 weeks is USD 72.47.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

NYSE: EW

Edwards Lifesciences Corporation

CEO	Mr. Bernard J. Zovighian
IPO Date	March 27, 2000
Location	United States
Headquarters	One Edwards Way
Employees	15,800
Sector	🏥 Health Care
Industries Medical Instruments 🔬 Clinical Trials 💻 Telehealth

Description

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.